Company intelligence / Profile preview

Scopio Labs

Tel Aviv, Tel Aviv, Israelscopiolabs.com ↗

Ownership: Private
Employees: ~150
Development stage: Commercial

Overview

Scopio Labs has developed FDA-cleared and CE-marked digital imaging platforms for full-field cell morphology analysis in hematology. Their solutions enable rapid, remote, high-resolution review of peripheral blood smears and bone marrow aspirates with integrated AI decision support. Clinical studies have shown significant reductions in diagnostic turnaround time—up to 60% faster for peripheral blood smear reviews—improving workflow efficiency and patient outcomes.

Therapeutic areas: Hematology
Modalities: DeviceAI-based diagnostic software
Industry: Pathology

Partnerships

No major pharmaceutical or biotech partnerships specifically named in available sources.

Beyond the preview

Go deeper on Scopio Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scopio Labs.

Explore the full profile